EV/EBITDA
-1.51
+0.09+5.62%
Sat, 01 Mar 2025 00:51:25 GMT
Summary
- As of March 2, 2025, TNGX EV/EBITDA is -1.51, with a rise of +0.09 (+5.62%) during the most recent trading day.
- Over the past year, TNGX EV/EBITDA has increased by +8.90 (+85.49%).
- TNGX EV/EBITDA is now at all-time high.
Performance
TNGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TNGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.6% | -5.8% | -5.4% |
| 1 m1 month | +35.5% | -35.5% | -33.8% |
| 3 m3 months | +49.5% | -49.5% | -47.7% |
| 6 m6 months | +83.7% | -82.8% | -81.7% |
| ytdytd | +35.7% | -35.7% | -34.0% |
| 1 y1 year | +85.5% | -82.2% | -82.2% |
| 5 y5 years | - | - | - |
TNGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -2.44 | +38.1% | |
| 3 m | 3-month | -1.51 | at high | -3.09 | +51.1% |
| 6 m | 6-month | -1.51 | at high | -9.62 | +84.3% |
| 1 y | 1-year | -1.51 | at high | -10.41 | +85.5% |
| 3 y | 3-year | -1.51 | at high | -12.04 | +87.5% |
| 5 y | 5-year | -1.51 | at high | -23.77 | +93.7% |
| alltime | all time | -1.51 | at high | -23.77 | +93.7% |
Tango Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.51(-35.7%) |
| 2024 | -2.35(-73.3%) |
| Date | Value |
|---|---|
| 2023 | -8.81(+55.4%) |
| 2022 | -5.67(-60.2%) |
| 2021 | -14.26 |
FAQ
- What is Tango Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Tango Therapeutics?
- What is TNGX EV/EBITDA year-to-date change?
- What is Tango Therapeutics EV/EBITDA year-on-year change?
What is Tango Therapeutics EV/EBITDA?
The current EV/EBITDA of TNGX is -1.51
What is the all time high EV/EBITDA for Tango Therapeutics?
Tango Therapeutics all-time high EV/EBITDA is -1.51
What is TNGX EV/EBITDA year-to-date change?
Tango Therapeutics EV/EBITDA has changed by +0.84 (+35.74%) since the beginning of the year
What is Tango Therapeutics EV/EBITDA year-on-year change?
Over the past year, TNGX EV/EBITDA has changed by +8.90 (+85.49%)